UCB acquires Duke genomics spin-out

UCB S.A. (Euronext:UCB) will acquire Duke University spin-out Element Genomics Inc. (Durham, N.C.) for up to $30 million comprising an upfront payment and milestones.

Element Genomics is using a suite of technologies and informatics to discover new therapies for severe diseases through the use of functional genomics and manipulation of the epigenome. UCB said the acquisition will help it enrich its pipeline by enhancing its capabilities for target discovery and characterization in disease relevant systems...